Evolving concepts in tumour lysis syndrome management - response to Ayed et al.

Jones, Gail L; Will, Andrew; Jackson, Graham H; Webb, Nicholas J; Rule, Simon

Evolving concepts in tumour lysis syndrome management - response to Ayed et al.

Jones, Gail L; Will, Andrew; Jackson, Graham H; Webb, Nicholas J; Rule, Simon.

Afiliación

Jones GL; Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. gail.jones@nuth.nhs.uk.
Will A; Department of Haematology, Royal Manchester Children's Hospital, Manchester, UK.
Jackson GH; Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Webb NJ; Department of Nephrology, Royal Manchester Children's Hospital, Manchester, UK.
Rule S; Department of Haematology, Derriford Hospital, Plymouth, Devon, UK.

Br J Haematol ; 173(3): 486-7, 2016 05.

Article en En | MEDLINE | ID: mdl-26216044

Asunto(s)

Síndrome de Lisis Tumoral; Humanos; Factores de Riesgo

Palabras clave

chemotherapy; immunotherapy; malignant haematology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Lisis Tumoral Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google